Acute pancreatitis requires immediate cessation of the medication
As research continues to unfold, Semaglutide holds the potential to make a significant impact on the lives of those struggling with excess weight.
No, semaglutide is FDA-approved only for subcutaneous injection and is not formulated or studied for intravenous use
This is why doctors have used semaglutide for years to treat type 2 diabetes prolonged levels of high blood sugar can cause side effects and health complications such as cardiovascular issues, kidney damage, neuropathy (nerve damage), eye problems such as diabetic retinopathy, slower healing of any wounds you get, foot ulcers due to blood vessel damage that can lead to amputation, increased susceptibility to infections, and sometimes cognitive decline
[95] Canada [edit] Semaglutide's pharmaceutical data exclusivity period expired in Canada in January 2026
Compounded semaglutide and split dosing Split dosing is almost exclusively relevant to people using compounded semaglutide from multi-dose vials
